# No culture? No problem: Clinical utility and pitfalls of non-culture diagnostics for pneumococcal parapneumonic effusions

## TL;DR

This paper reviews non-culture diagnostic methods for detecting pneumococcal infections in parapneumonic effusions, comparing their benefits and limitations against traditional culture techniques.

## Contribution

The paper provides a comprehensive analysis of non-culture diagnostic methods for pneumococcal parapneumonic effusions, emphasizing their clinical utility and challenges.

## Key findings

- Non-culture methods like antigen tests and PCR offer faster and more sensitive alternatives to traditional cultures.
- Urinary and pleural fluid antigen tests are practical but prone to false positives and negatives.
- PCR provides high specificity and serotype identification but is costly and less accessible.

## Abstract

Community acquired pneumonia is the primary cause of hospital admission and the most common infectious cause of mortality in developed countries, with parapneumonic effusion and empyema representing frequent complications. Because Streptococcus pneumoniae is the leading microbial cause, accurate diagnostic methods with high sensitivity and specificity are crucial to guide effective, narrower-spectrum anti-microbial therapy. This narrative review analyzes culture-independent methods for the diagnosis of pneumococcal parapneumonic effusions, including urinary antigen detection, pleural fluid antigen detection, and polymerase chain reaction, comparing their performance and highlighting key advantages and limitations. While cultures of blood, sputum, and pleural fluid remain the diagnostic gold standard, they have low sensitivity, are time-consuming, and are often affected by prior antibiotic exposure. Non-culture methods provide faster and sometimes more sensitive alternatives: urinary and pleural fluid antigen tests are rapid and practical but risk false positives and negatives, whereas polymerase chain reaction-based techniques offer high specificity and serotype identification but remain costly and less widely available. Emerging approaches such as proteomics and next-generation sequencing may expand diagnostic capabilities in the future. Culture-independent methods therefore hold clinical value in culture-negative cases and can complement traditional techniques, but cultures remain essential for confirmation and antibiotic susceptibility testing, underscoring the need for further adult-focused studies.